Alcorn, M., 2008. How to carry out a field investigation, in: Pattison, M., McMullin, P., Bradbury, J.M., Alexander, D.J. (Eds.), Poultry Diseases 6th ed. Elsevier, London, pp.14-47.
Ameiss, K.A., El-Attrache, J., Brewer, A., McElroy, A.P., Caldwell, D.J., 2006. Influence of orally administered CpG-ODNs on the humoral response to bovine serum albumin (BSA) in chickens. Vet.Immunol.Immunopathol. 110(3-4), 257-267.
Azmi, F., Ahmad Fuaad, A.A.H., Skwarczynski, M., Toth, I., 2014. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother. 10(3), 778-796, DOI: 10.4161/hv.27332.
Barr, A., 2004. Effects of Cytosine-phosphate-Guanosine Oligodeoxynucleotides (CpG-ODN) on vaccination and immunization of neonatal chickens. MS thesis, Texas A&M University, Texas, USA.
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., Klinman, D.M., 2011. CpG DNA as a vaccine adjuvant. Expert Rev.Vaccines 10(4), 499–511.
Campbell, T.W., 1992. Avian Hematology and Cytology. 1st ed. Iowa State University Press, Ames, USA.
Chrzastek, K., Borowska, D., Kaiser, P., Vervelde, L., 2014. Class B CpG ODN stimulation upregulates expression of TLR21 and IFN-γ in chicken Harderian gland cells. Vet.Immunol.Immunopathol. 160(3-4), 293-299.
Collett, S.R., 2013. Principal of disease prevention, diagnosis and control introduction, In: Swayne, D.E. (Editor-in-Chief). Diseases of Poultry 13thed. Wiley-Blackwell, Oxford, pp. 4-40.
Dimitrov, K.M., Afonso, C.L., Yu, Q., Miller, P.J., 2017. Newcastle disease vaccines—A solved problem or a continuous challenge? Vet.Microbiol. 206, 126–136.
El-Tayeb, G.A., El-Ttegani, M.Y., Hajer, I.E.,Mohammed, M.A., 2013. The immuneresponse of maternally immune chicks to vaccination with Newcastle disease virus. Bull.Anim.Health.Prod.Afr. 61(4), 603-612.
Fu, J., Liang, J., Kang, H., Lin, J., Yu, Q., Yang, Q., 2013. Effects of different CpG oligodeoxynucleotides with inactivated avian H5N1 influenza virus on mucosal immunity of chickens. Poult.Sci. 92(11), 2866-2875.
Gomis, S., Babiuk, L., Godson, D.L, Allan, B., Thrush, T., Townsend, H., et al., 2003. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infec.Immun. 71(2), 857-863.
Gunawardana, T., Foldvari, M., Zachar, T., Popowich, S., Chow-Lockerbie, B., Vaneva Ivanova, M., et al., 2015. Protection of neonatal broiler chickens following in ovo delivery of oligodeoxynucleotides containing CpG motifs formulated with carbon nanotubes or liposomes. Avian Dis. 59(1), 31-37.
Gupta, S.K., Bajwa, P., Deb, R., Chellappa, M.M., Dey, S., 2014. Flagellin a toll-like receptor-5 agonist as an adjuvant in chicken vaccines. Clin.Vaccine.Immunol. 21(3), 261-270.
Hartley, C., Salisbury, A.M., Wigley, P., 2012. CpG oligdeoxyonucleotides and recombinant interferon-γ in combination improve protection in chickens to Salmonella enterica serovar Enteritidis challenge as an adjuvant component, but have no effect in reducing Salmonella carriage in infected chickens. Avian Path. 41(1), 77-82.
Huang, C.F., Wang, C.C., Wu, T.C., Chu, C.H., Peng, H.J., 2007. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic Th 2 immune responses and mucosal immunity in mice. Ann.Allerg.Asthma.Immunol. 99(5), 443-452.
Jacobs, E.B., Owoade, A.A., Oyekunle, M.A., Talebi, A.O., Oni, O.O.,2014. Evaluation of maternally-derived antibodies against newcastle disease virus in day-old chicks in abeokuta, ogun state. J.Agric.Sci.Env. 14(1), 118-123.
Linghua, Z., Xingshan, T., Frengzhen, Z., 2007. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides inducesspecific immunity and protection against Newcastle disease virus in SPF chicken. Vet.Immunol.Immunopathol. 115 (3-4), 216-222.
Miller, P.J., Koch, G., 2013. Newcastle disease, in: Swayne, D.E. (Editor-in-Chief), Diseases of Poultry, 13th edn. Wiley-Blackwell, Oxford, pp. 89-107.
Mena, A., Nichani, A.K., Popowych, Y., Godson, D.L., Dent, D., Townsend, H.G., et al., 2003. Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells. Immunol. 110(2), 250–257.
Mount, A., Koering, S., Silva, A., Drane, D., Maraskovsky, E., Morelli, A.B., 2013. Combination of adjuvants: The future of vaccine design. Exper. Rev. Vaccines. 12(7), 733-746.
Scheiermann, J., Klinman, D.K., 2014. Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer. Vaccine. 32(48), 6377–6389. Doi:10.1016/j.
St Paul, M., Barjesteh, N., Brisbin, J.T., Villaneueva, A.I., Read, L.R., Hodgins, D., et al., 2014. Effects of ligands for Toll-like receptors 3, 4, and 21 as adjuvants on the immunogenicity of an avian influenza vaccine in chickens. Viral Immunol. 27(4), 167-173.
Völlmer, J., Weeratnam, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H.L., Krieg, A.M., 2004. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur.J.Immunol. 34(1), 251-262.
Walberg, J., 2001. White blood cell counting techniques in birds. Seminars in Avian and Pet Medicine. 10(2): 72-76.
Yu, C., An, M., Li, M., Liu, H., 2017. Immunostimulatory properties of lipid modified CpG Oligonucleotides. Mol.Pharm. 14(8), 2815-2823. doi: 10.1021/acs.
Xie, H., Raybourne, R.B., Babu, U.S., Lillehoj, H.S., Heckert, R.A., 2003. CpG-induced immunomodulation and intracellular bacterialkilling in a chicken macrophage cell line. Dev.Comp.Immunol. 27 (9), 823–834.
Zhang, L., Tian, X., Zhou, F., 2007. Intranasal administration of CpG oligodeoxynucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo. Int.Immunopharmacol. 7(13), 1732–1740.
Zhang, L., Zhang, M., Li, J., Cao, T., Tian, X., Zhou, F., 2008. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligodeoxynucleotide in SPF chickens in vivo. Res.Vet.Sci. 85(3), 495-502.
|